IGFL2 and bladder transitional cell carcinoma: IGFL2 expression was positively correlated with immune checkpoint genes in almost all cancers, with positive correlations with most immune checkpoints demonstrated in BLCA, BRCA, KIRC, KIRP, LIHC, LUAD, OV, THCA UCEC, UCS and UVM.